Synexa Life Sciences
Parveen Sobia is an accomplished scientist with extensive experience in bioanalytical marker optimization, development, and validation at Synexa Life Sciences since September 2022. In addition to this role, Parveen serves as an honorary lecturer at the University of KwaZulu-Natal and has held positions as a postdoctoral scientist at CAPRISA and a medical student facilitator at the Nelson R Mandela School of Medicine. Parveen's research background includes a postdoctoral fellowship at the University of KwaZulu-Natal and a research fellowship at ICGEB. Educational qualifications include a PhD in Medical Microbiology from the University of KwaZulu-Natal, a Master's degree in Biotechnology from Jiwaji University, and a Bachelor of Science in Zoology from Delhi University. Parveen is trained in GCP/GCLP and follows FDA/EMA guidelines for validation, with a specialization in novel immunological assays, particularly ELISA, MSD, and cell-based assays.
This person is not in any offices
Synexa Life Sciences
Synexa Life Sciences is a global provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays. With a team of 150 across five global laboratory locations; Cape Town, London, Berlin, Turku (Finland) and Rockville (Maryland USA), we provide innovative solutions to support our customers to achieve their clinical milestones. Our main areas of expertise include biomarker identification and development, clinical bioanalysis, soluble biomarker analysis (utilising MSD, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genomic services to support clinical trials and translational studies. We pride ourselves on our deep scientific expertise and our ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis. We partner with our customers to contribute to the furtherment of scientific development and ultimately better management and treatment of human health. Synexa, improving the quality of human health through innovative biomarker and bioanalytical solutions.